Gen. Mgr., Precision Oncology
Fri, Aug 4, 2023
Aug 4
exercised or converted securities in EXAS
2,712 shares @ $0.00
Decreased holdings by -50.00%
Net across this filing: +18.10% (+1,362 shares)
Option Exercise
Sale tied to a same-time option exercise
EXASEXACT SCIENCES CORP
Health CareHealth Care Services